Navigation Links
New Institute Targets Brain Tumor Survival

Northwestern Brain Tumor Institute seeks to bridge translational gaps between cancer research and cutting-edge therapy to lower brain tumor death rates

CHICAGO, Jan. 22 /PRNewswire-USNewswire/ -- Primary brain tumors affect nearly 20,000 Americans each year -- and every year more than half die as a result. For young adults ages 30-39, brain tumors are the third-leading cause of death among men and the fifth-leading among women. Despite significant advances in cancer treatment, on average, adults with glioblastoma, the most common malignant brain tumor, survive roughly 12 to 14 months post diagnosis.

"Currently less than one-third of adults survive five years after being diagnosed with a primary brain tumor," says Jeffrey Raizer, MD, director of medical neuro-oncology at Northwestern Memorial Hospital and co-director of the Northwestern Brain Tumor Institute. "Our mission is to improve patient survival through clinical and scientific research."

The Northwestern Brain Tumor Institute is a collaboration of Northwestern Memorial, the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Northwestern University's Feinberg School of Medicine. It was established to merge medical research with state-of-the-art, comprehensive care to better manage and treat patients with brain tumors. In addition, the Institute emphasizes therapeutic approaches that preserve quality of life while taking every measure possible to extend life.

"Brain tumor treatment is very complicated," says James Chandler, MD, Northwestern Memorial's surgical director of neuro-oncology and the Institute's other co-director. "The very therapy that may eradicate malignancies may also diminish quality of life for some patients."

The Institute's three-pronged approach rests upon surgery, medical treatment and clinical research. With surgery for example, advanced neuro-imaging techniques, neuro-navigation and brain mapping, makes brain tumor surgery much more precise than in years past. And, through minimally invasive endoscopic skull-based procedures, brain tumors can be accessed through the patient's nose, eliminating the need to split the face and skull.

With medical treatment, the neuro-oncology team provides an extensive list of cutting-edge chemotherapies offered through clinical trials. In addition, medical treatment is uniquely integrated with psychosocial therapy options like monthly support groups and a Brain Tumor resource center. The rapid growth of Northwestern's clinical neuro-oncology programs has lead to the natural evolution of growth within the sciences.

"Our academic medical center does not rely solely on clinical trials developed by outside pharmaceutical companies," commented Markus Bredel, M.D., Ph.D., director of the Brain Tumor Institute's research program. "We also develop a number of our clinical trials in-house based on our own findings, our collective knowledge and medical expertise, which truly makes us unique."

One example of this is evident in a new initiative of the Brain Tumor Institute to collect and study all tumor specimens in order to better understand tumor biology. Also known as molecular profiling, by studying the biological progression of tumors and certain consistencies within tumors can be identified allowing researchers to target therapies and tailor treatment regimens that are extended to patients.

Chandler summates, "Our multidisciplinary approach encompasses research, neuro-oncology, neurosurgery and clinical programming in such a way that we hope to set forth new global standards for effectively managing the disease as well as a model of care with potential to improve outcomes and hopefully contribute to finding a cure."

For more information about the Northwestern Brain Tumor Institute, its experts and its programs, visit

About Northwestern Memorial Hospital

Northwestern Memorial Hospital is one of the country's premier academic medical centers and is the primary teaching hospital of the Northwestern University Feinberg School of Medicine. Along with its Prentice Women's Hospital and Stone Institute of Psychiatry, the hospital comprises 873 beds, 1,554 affiliated physicians and 6,747 employees. Northwestern Memorial is recognized for providing exemplary patient care and state-of-the art advancements in the areas of cardiovascular care; women's health; oncology; neurology and neurosurgery; solid organ and soft tissue transplants and orthopaedics.

Northwestern Memorial possesses nursing Magnet Status, the nation's highest recognition for patient care and nursing excellence, and it is listed in 10 clinical specialties in U.S. News & World Report's 2008 "America's Best Hospitals" guide. For nine years running, it has been rated among the "100 Best Companies for Working Mothers" guide by Working Mother magazine. The hospital is a recipient of the prestigious National Quality Health Care Award and has been chosen by Chicagoans as their "most preferred hospital" according to the National Research Corporation's annual survey for 10 years.

SOURCE Northwestern Memorial Hospital
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New institute targets brain tumor removal
2. Hearing Aids Offer Hope for Those Who Suffer from Persistent Ringing in the Ears, Better Hearing Institute Survey Finds
3. Dana-Farber Cancer Institute Chooses MicroStrategy for Clinical Operations and Clinical Research Reporting Applications
4. Photos: Apples iPhone Finds New Use in Treating Stuttering at Hollins Communications Research Institute
5. Health Care Compliance Association to Hold 13th Annual Compliance Institute, April 26-29, 2009, Caesars Palace, Las Vegas, NV
6. May Institute Launches Pediatric Specialty Center in Santa Clara County
7. The Khanna Institute of Lasik Surgery Offers Better Vision for the Chinese New Year
8. University of Ottawa Heart Institute Scientists Successfully Develop Novel Biomaterial to Help Grow New Blood Vessels
9. NeuroTexas Institute at St. Davids HealthCare Launches Consultative Scan Review Program for Physicians and Patients Seeking Second Opinion
10. Michigan CardioVascular Institute Selects Sage Intergy EHR to Streamline Clinical, Workflow and Reporting Efficiencies
11. AMERIGROUP to Establish Public Policy Institute
Post Your Comments:
(Date:12/1/2015)... PA (PRWEB) , ... December 01, 2015 , ... ... imaging facilities, radiographic technicians must mark the film for accurate interpretation by the ... track of. Fortunately, an inventor from Sacramento, Calif., has found a way to ...
(Date:12/1/2015)... ... 2015 , ... McLean, VA., December 1, 2015 - Octo ... sprint agile development contract to support the National Geospatial-Intelligence Agency's (NGA) IT Services ... engineering, infrastructure, as well as operations and sustainment support to the NGA’s Agile ...
(Date:12/1/2015)... ... December 01, 2015 , ... PartnerTech , ... membership and leadership since 2008. Gary Bruce, President of PartnerTech North America, currently ... spent a significant amount of time in Sweden since joining PartnerTech based in ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... Center Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation recognizes Tympani ... support Cisco Unified Contact Center solutions targeted to the high-end enterprise contact center ...
(Date:11/30/2015)... NY (PRWEB) , ... December 01, 2015 , ... ... honors Christina Colon as a 2015-2016 inductee into its VIP Woman ... in pharmacy. NAPW is the nation’s leading networking organization exclusively for professional women, ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Dec. 1, 2015  Lexicon Pharmaceuticals, Inc. ... top-line data from its TELECAST Phase 3 ... treating carcinoid syndrome in cancer patients with ... benefit observed in its pivotal TELESTAR study.  ... companion to TELESTAR primarily to provide additional ...
(Date:12/1/2015)... , Dec. 1, 2015  ImmunoCellular Therapeutics, ... Andrew Gengos , President and Chief ... on December 3, 2015. Mr. Gengos plans ... registrational program in patients with newly diagnosed ... TIME:    12:15p.m. ET/9:15a.m. PT LINK: ...
(Date:12/1/2015)... and UPPSALA, Sweden , December ... been selected by the International Breast Cancer Study Group (IBCSG, ... (BIG, Brussels ) to be part of ... palbociclib, a promising new cancer drug.  --> ... women with advanced breast cancer being treated with anti-hormonal therapy ...
Breaking Medicine Technology: